Jamp Pharma has initiated a recall due to the potential presence of particulate matter in vials from affected lots of AJ-PIP/TAZ (Piperacillin and Tazobactam) for Injection (see table below). The presence of particulate matter could pose the following risks, if injected: local inflammation, phlebitis, allergic response and/or embolization in the body and infection.